Eli Lilly and Company (SWX:LLY)
Switzerland · Delayed Price · Currency is CHF 595.00
+5.00 (0.85%)
At close: Sep 4, 2025
Eli Lilly and Company Employees
Eli Lilly and Company had 47,000 employees as of December 31, 2024. The number of employees increased by 4,000 or 9.30% compared to the previous year.
Employees
47,000
Change (1Y)
4,000
Growth (1Y)
9.30%
Revenue / Employee
901.17K CHF
Profits / Employee
233.51K CHF
Market Cap
537.70B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Lonza Group AG | 18,944 |
| Galderma Group AG | 6,545 |
| Alcon | 25,599 |
| Sandoz Group AG | 22,049 |
| Straumann Holding AG | 11,815 |
| Sonova Holding AG | 18,366 |
Eli Lilly and Company News
- 1 day ago - Thousands in England unable to access weight loss jabs via GP, figures reveal - The Guardian
- 1 day ago - Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors - Benzinga
- 1 day ago - Lila Biologics Announces Collaboration with Lilly For Radioligand Therapy Discovery and Development - GlobeNewsWire
- 1 day ago - Alexandria Real Estate Equities, Inc. Named One of the World's Most Trustworthy Companies by Newsweek for the Second Consecutive Year - Benzinga
- 1 day ago - Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain newly diagnosed metastatic KRAS G12C-mutant lung cancers - PRNewsWire
- 1 day ago - Where Will Eli Lilly Be in 3 Years? - The Motley Fool
- 1 day ago - Eli Lilly's Stock Fall Is An Opportunity - Seeking Alpha
- 2 days ago - Global drugmakers rush to boost US presence as tariff threat looms - Reuters